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Background: The staphylococci are implicated in a variety of human infections; however, many clinical
microbiology laboratories in Nigeria do not identify staphylococci (in particular coagulase negative
staphylococci - CNS) to the species level. Moreover, data from multi-centre assessment on antibiotic resistance
and epidemiology of the staphylococci are not available in Nigeria. This study investigated 91 non-duplicate
staphylococcal isolates obtained from the microbiology laboratories of eight hospitals in Nigeria during the
period January to April 2010.
Methods: Identification and antibiotic susceptibility testing was performed using the VITEK 2 system, detection of
resistance genes by PCR, and molecular characterization was determined by SCCmec typing, spa and multilocus
sequence typing (MLST).
Results: All the isolates were susceptible to mupirocin, tigecycline, vancomycin and linezolid, but 72.5% of CNS
and 82.3% of Staphylococcus aureus were resistant to cotrimoxazole, while multiresistance was observed in 37
of the 40 CNS isolates. Untypeable SCCmec types (ccrC/Class A mec and ccr-negative/Class C2 mec gene complex)
in two methicillin-resistant S. aureus (MRSA) were identified. Additionally, ccr-negative/Class A mec and ccr type 4/
Class C2 mec gene complex was detected in one isolate each of S. sciuri and S. haemolyticus, respectively.
The S. aureus isolates were classified into 21 spa types including two new types (t8987, t9008) among the
methicillin-susceptible S. aureus (MSSA) isolates. Two (CC8-SCCmecnon-typeable and CC88-SCCmec IV) and
four (CC8-SCCmec III/IV/V; CC30-SCCmec II/III; CC88-SCCmec IV; and ST152-SCCmecnon-typeable) MRSA clones
were identified in Maiduguri (North-East Nigeria) and South-West Nigeria, respectively. The proportion of
Panton-Valentine leukocidin (PVL)-positive MSSA was high (44.4%) and 56.3% of these strains were associated
with sequence type (ST) 152.
Conclusions: The identification of multiresistant mecA positive S. haemolyticus and S. sciuri from clinical samples
indicates that characterization of CNS is important in providing information on their diversity and importance in
Nigeria. There is the need to develop new SCCmec classification methods for non-typeable methicillin-resistant
staphylococci, and to curtail the spread and establishment of the S. aureus ST152 clone in Nigeria. The study
presents the first report of a PVL-positive ST152-SCCmecnontypeable MRSA and SCCmec typing of
methicillin-resistant CNS in Nigeria.
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The staphylococci are part of the normal cutaneous
ecosystem, but they are also opportunistic and invasive
pathogens that cause a variety of human infections.
Staphylococcus aureus is the most important human
pathogen in this genus accounting for a high proportion
of severe infections in hospitals and outpatient med-
ical care [1-3]. Although the clinical relevance of coagu-
lase negative staphylococci (CNS) is still controversial,
patients at risk of CNS infections include neonates,
those with intravascular catheters, prosthetic devices,
postoperative sternal wound infections and immuno-
compromised hosts [4-7]. The remarkable ability of
S. aureus and CNS to acquire antibiotic resistance limits
therapeutic options, and morbidity and mortality rates
of staphylococcal infections have increased the financial
burden on health care systems worldwide [8-14].
Although there are reports on the characterization of
staphylococci in Nigeria [15-18], many of the studies
were limited to antibiotic susceptibility profiles. More-
over, one geographical region or health care institution
was investigated, and CNS were not identified to species
level. Only a few studies have investigated the molecular
epidemiology and diversity of this group of organisms
[19-23], however, they were not multi-centre surveys on
S. aureus and CNS. This work describes a multi-centre
study which was conducted in order to provide clinicians
and infection control practitioners with information on
antibiotic resistance profiles, molecular characteristics of
coagulase positive and negative staphylococci, and to
alert clinicians to the emergence of new clones in health
care institutions (HCIs) in Nigeria.Methods
Isolation and identification of staphylococcal isolatess
The study commenced with the request for non-
duplicate staphylococcal isolates obtained from clinical
samples processed in the microbiology laboratories of
eight health care institutions in Ile-Ife, Ogbomosho, Iwo,
Lagos (two centres) and Ibadan in South-West Nigeria;
Jos in North-Central Nigeria, and Maiduguri in North-
East Nigeria (Figure 1) during the period January to
April, 2010. In this study, only staphylococcal isolates
were analyzed and human subjects, clinical samples or
human data were not investigated. All the hospitals,
except the one located in Iwo, were tertiary health care
institutions, each of which were at least 500-bed facilities
providing medical care to about 500,000 to one million
people. Preliminary verification as staphylococci was
based on culture characteristics on blood agar, catalase,
coagulase and DNase tests, while identification to spe-
cies level was performed at the National Health Labora-
tory Service (NHLS), Groote Schuur Hospital, CapeTown, South Africa using the VITEK 2 system (bioMér-
ieux, France) with the Gram-Positive Identification Card.
Antibiotic susceptibility testing
Antibiotic susceptibility for penicillin G, oxacillin, teico-
planin, vancomycin, gentamicin, tetracycline, ciprofloxacin,
moxifloxacin, trimethoprim/sulfamethoxazole (cotrimox-
azole), fusidic acid, erythromycin, clindamycin, rifampi-
cin, mupirocin, linezolid and tigecycline was determined
by the broth microdilution method (VITEK 2 system,
AST 603 cards, bioMérieux). S. aureus ATCC 29213 was
the control strain and the VITEK 2 minimum inhibitory
concentration (MIC) results were interpreted using
the Advanced Expert System of the VITEK 2. Multiresis-
tance was defined as resistance to at least three classes
of antibiotics.
DNA extraction
Before DNA extraction, 5–8 colonies from an 18–24 h
old culture on boiled blood agar was pretreated with
lysostaphin (Sigma) (20 μg/ml for S. aureus; 50μg/ml
for CNS) in 20 mM Tris-Cl, 2mM EDTA at 37°C for
30 min. The cells were harvested and DNA was isolated
using a DNeasy tissue kit (Qiagen, Hilden, Germany).
PCR detection of the tuf gene
Phenotypic identification of the S. aureus isolates
was confirmed by detection of the tuf gene as described
previously [24]. The PCR products were detected by
gel electrophoresis using 2% w/v agarose (Seakem,
Whittaker, USA) and run in 1X TAE buffer (pH 8.3) for
1 h at 100 V. Thereafter, the gel was stained with eth-
idium bromide, visualized under UV light and photo-
graphed using a SynGene Bioimaging System.
PCR detection of the dfrA gene
The presence of the dfrA gene encoding trimethoprim
resistance was investigated using the primer pairs: dfr-
AF: AAT AGA CGT AAC GTC GTA CT; dfr-AR: AAG
AAT GTA TGC GGT ATA GT and subsequent detec-
tion of a 289 bp product [25]. The PCR conditions were
as follows: Initial denaturation at 95°C for 3min, fol-
lowed by 30 cycles of amplification at 95°C for 30s,
annealing at 55°C for 30s, extension at 72°C for 30s and
final extension at 72°C for 1min.
SCCmec typing
SCCmec typing was performed according to a previously
published protocol [26] using the control strains S. aur-
eus COL (type I), N315 (type II), ANS46 (type III),
MW2 (type IV), WIS (type V) and HDE288 (type VI).
For non-typeable SCCmec elements, the investigation
of mec complexes and ccr allotypes as described by
Kondo et al. [27] was carried out on representative
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Figure 1 Map indicating the location of the health care institutions in Nigeria.
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based on their spa-MLST profile and location of the
health care institutions, respectively. The profiles
obtained were characterized and defined according to
the current nomenclature used for MRSA [28].
Detection of the PVL gene
The presence of the PVL gene was determined by PCR
using primers luk-PV-1 and luk-PV-2 [29].
Genotyping
Typing of S. aureus was based on sequencing of the
hypervariable region of the protein A gene (spa). The
spa types were assigned using the Ridom StaphType
(Ridom GmbH, Würzburg, Germany, version 1.5.21)
[30]. Multilocus sequence typing (MLST) was carried
out according to the protocols described previously [31]
on a representative isolate for the predominant and new
spa types. PCR products were purified and sequenced at
the Central Analytical Facility at the University of Stel-
lenbosch, South Africa. Allelic profiles and sequence
types (STs) were assigned using the MLST S. aureus
database (www.mlst.net). Isolates that were not typed by
MLST were assigned STs based on the Based Upon Re-
peat Pattern (BURP) via the Ridom StaphType software.
Results
Identification and source of the staphylococcal isolates
Preliminary verification of isolates obtained from the
microbiology laboratories in eight HCIs in Nigeria iden-
tified 91 staphylococcal isolates (51 S. aureus and
40 CNS) and the characteristics of each isolate arepresented in Tables 1, 2 and 3. The clinical S. aureus iso-
lates were recovered from wounds, skin and soft tissue
infections (SSI), osteomyelitis and burns (36.4%), geni-
tourinary tract infection (GTI)/infertility (18.2%), septi-
caemia (15.9%), urinary tract infection (UTI) (6.8%),
otitis media (6.8%), bronchitis (4.5%), and 11.4% were
classified as other infections (Tables 1 and 2). Six species
accounted for the CNS isolates: S. haemolyticus (n=21),
S. sciuri (n=9), S. saprophyticus (n=5), S. warneri (n=3),
S. epidermidis (n=1) and S. hominis (n=1), which were
distributed across four HCIs located in Ogbomosho,
Lagos (designated as Lagos2), Jos and Maiduguri
(Table 3). Most of the S. haemolyticus isolates were from
the centres in Lagos2, Jos and Maiduguri, and 47.6% of
the isolates were obtained from septicaemia, 14.3% from
wound infections, 9.5% each from GTI, UTI, ocular-
related infections, and those categorised as other infec-
tions (Table 3).
Antibiotic susceptibility of the staphylococcal isolates
and detection of mecA and dfrA genes
All the staphylococcal isolates were susceptible to mupir-
ocin, tigecycline, vancomycin and linezolid (Table 4). In
addition to the antibiotics stated above, the methicillin-
susceptible S. aureus (MSSA) were susceptible to teico-
planin, gentamicin, erythromycin, clindamycin, fusidic
acid and rifampicin. About 94% of MSSA were suscep-
tible to the fluoroquinolones and one isolate was suscep-
tible to all the antibiotics tested. However, 80.6% of
MSSA were resistant to cotrimoxazole and penicillin, but
all the cotrimoxazole-resistant MSSA were dfrA negative.
The predominant antibiotype was resistance to penicillin,






















50 Lagos1 Burns PEN, OXA, GEN, CIP, MOX,
ERY, CLI*, TET, COT, RIF
+ + + III - t037 ST241 CC8
2496ψ Maiduguri GTI PEN, OXA, GEN, CIP, ERY,
CLI, TET, COT
+ + - NT/UNT - t037**
2589 Maiduguri GTI PEN, OXA, GEN, CIP, ERY,
CLI, TET, COT
+ + - NT - t037
60ψ Lagos1 ASOM PEN, OXA, TET, COT + + - NT/V - t064** ST8 CC8
69¶ Lagos1 Nasal swab/
Screening
PEN, OXA, GEN, TET, COT + + - NT - t064
T39sB Iwo HIV/AIDS PEN, OXA, TET, COT + + - NT - t064
T6530 Ile-Ife Osteomyelitis PEN, OXA, GEN, CIP, TET, COT + + - IV - t064
TU32 Ibadan Wound Infection PEN, OXA, CIP, TET, COT + + - NT - t064
TU3ψ Ibadan Wound Infection PEN, OXA, CIP, TET, COT + + - NT/V - t064
T5056 Ile-Ife Bronchitis PEN, OXA, GEN, CIP, ERY,
CLI*, TET, COT, FUS, RIF
+ + - III - t074 ST37 CC30
TD17 Ile-Ife Bronchitis PEN, OXA, ERY, CLI + + ND II - t007 ST39
TN45 Ile-Ife Wound Infection PEN, OXA, TET + + ND IV - t729 ST88 CC88
003B Maiduguri Septicaemia PEN, OXA, TET, COT + + + IV - t1603
008 Maiduguri Septicaemia PEN, OXA, COT + + + IV - t1603
T5843ψ Ile-Ife Osteomyelitis PEN, OXA, TET, COT + + - NT/UNT + t4690** ST152 singleton
KEY:
ψ: Representative MRSA for SCCmec typing determined by Kondo et al. (2007).
¶Nasal samples of health care workers (HCWs) in one of the hospitals in Lagos (designated as Lagos1).
Geographical region (Nigeria): South-West (Ile-Ife, Ibadan, Iwo and Lagos); North-East (Maiduguri); North Central (Jos).
GTI: Genital Tract Infection; ASOM: Acute suppurative otitis media.
Antibiotics - PEN: Penicillin; OXA: Oxacillin; GEN: Gentamicin; CIP: Ciprofloxacin; MOX: Moxifloxacin; ERY: Erythromycin; CLI: Clindamycin; TET: Tetracycline; FUS:
Fusidic acid; RIF: Rifampicin; COT: Cotrimoxazole; *: Inducible resistance (clindamycin).
UNT: Untypeable SCCmec types; NT: Non-typeable; ND: Not determined.
Isolates with spa type t007, t074, t729 and t1603 were assigned STs based on the Based Upon Repeat Pattern (BURP) via the Ridom StaphType software.
**: MLST on representative strains.
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14 isolates (39%). Resistance to oxacillin was detected in
15 S. aureus isolates and confirmed as MRSA by the de-
tection of the mecA gene. Of the 15 MRSA isolates, 13
were resistant to cotrimoxazole and tetracycline, while 6
and 7 MRSA were resistant to gentamicin and ciproflox-
acin, respectively. Two of the 5 erythromycin-resistant
MRSA expressed inducible resistance to clindamycin.
Overall, 12 of the 15 MRSA were resistant to at least three
classes of antibiotics (Table 1). The trimethoprim resist-
ance gene, dfrA, was detected in only 3 MRSA isolates.
All the S. haemolyticus isolates were resistant to peni-
cillin, oxacillin and cotrimoxazole, but only one isolate
exhibited resistance to fusidic acid. The proportion of
S. haemolyticus isolates resistant to ciprofloxacin, genta-
micin and tetracycline was 80.9%, 85.7% and 90.5%,
respectively (Table 4). Furthermore, 5 (50%) of the 10
erythromycin-resistant S. haemolyticus isolates expressed
inducible resistance to clindamycin, and one isolate
showed intermediate resistance to teicoplanin (MIC:
16μg/ml). Multiresistant S. haemolyticus isolates wererecovered from clinical samples in four HCIs in Lagos2,
Maiduguri, Jos and Ogbomosho (Table 3). In contrast,
resistance to fusidic acid was common in other species
of CNS, and they were susceptible to erythromycin, clin-
damycin, teicoplanin and rifampicin (Table 4). The
S. sciuri isolates were resistant to oxacillin and obtained
primarily from various clinical samples in Ogbomosho
(Table 3). On the whole, multiresistance was observed in
37 of the 40 CNS isolates, and the CNS isolates identi-
fied as methicillin-resistant (VITEK) were mecA positive.
SCCmec typing
Fifteen MRSA were obtained from the HCIs in Ile-Ife
(n=5); Maiduguri (n=4); Lagos1 (n=3); Ibadan (n=2) and
Iwo (n=1). Using the multiplex typing method [26],
SCCmec type IV was identified in two MRSA each from
Ile-Ife and Maiduguri, SCCmec type III in two MRSA,
one each from Ile-Ife and Lagos1, and SCCmec type II
in one MRSA from Ile-Ife (Table 1). However, 8 of 15
MRSA and 28 methicillin-resistant CNS (MRCNS) were
non-typeable. Based on another PCR-based method [27],


















1229 Maiduguri GTI TET + ND - t311 ST5 CC5
652 Maiduguri Not available PEN, COT + - + t311
47 Lagos1 Leg Ulcer PEN, TET, CIP, MOX, COT + - - t064 CC8
54 Lagos1 SLE PEN, TET, COT, CIP + - - t064
49¶ Lagos1 Nasal swab/screening PEN, COT + - - t2331** ST8
10 Ogbomosho SSI PEN + ND + t084 CC15
62 Lagos1 UTI COT + - - t084
076 Maiduguri Not available PEN, TET, COT + - - t084
373 Maiduguri UTI COT, TET + - - t084** ST15
1253 Maiduguri SSI PEN, TET, COT + - - t084
2290 Maiduguri SSI PEN, TET, COT + - - t084
2696 Maiduguri Semen (Infertility) PEN, COT + - - t084
1038 Maiduguri SSI PEN, COT + - + t2216
2478 Maiduguri UTI PEN, TET, COT + - - t2216
6B Ogbomosho Septicaemia COT + - + t318 ST30 CC30
51¶ Lagos1 Nasal swab/screening PEN, COT + - - t318
1059 Maiduguri GTI COT + - - t318
2578 Maiduguri GTI PEN, TET, COT + - + t934 ST80 CC80
56 Lagos1 Otitis media PEN, COT + - - t159 ST121 CC121
67¶ Lagos1 Nasal swab/screening PEN, TET, COT + - + t2304
68¶ Lagos1 Nasal swab/screening PEN, TET, COT + - + t2304
006 Maiduguri Septicaemia PEN, TET, COT + - + t355** ST152 singleton
0017 Maiduguri Septicaemia PEN, TET, COT + - + t355
1097 Maiduguri SSI PEN, TET, COT + - + t355
2365 Maiduguri Semen (Infertility) PEN, COT + - + t355
259 Maiduguri Semen (Infertility) PEN, COT + - + t355
604 Maiduguri SSI PEN, TET, COT + - - t355
642 Maiduguri SSI PEN, TET + ND + t9008**
829 Maiduguri SSI PEN, TET + ND - t9008
J11 Jos Septicaemia PEN, TET, COT + - + t355
J13 Jos Septicaemia PEN, TET, COT + - + t355
61 Lagos1 SSI TET, COT + - + t8987**
64¶ Lagos1 Nasal swab/screening PEN + ND - t1510 ST508 CC45
55 Lagos1 CSOM PEN + ND - t8223 ND CC45
57 Lagos1 Haematoma Susceptible to all antibiotics + ND - t635 ND ND
70¶ Lagos1 Nasal swab/screening PEN, TET, COT + - - NT ND ND
KEY:
¶: Nasal samples of health care workers (HCWs) in one of the hospitals in Lagos (designated as Lagos1).
GTI: Genital Tract Infection; SLE: systemic lupus erythematosus; SSI: Skin and soft tissue infection; UTI: Urinary Tract Infection; CSOM: Chronic suppurative
otitis media.
Antibiotics - PEN: Penicillin; TET: Tetracycline; CIP: Ciprofloxacin; MOX: Moxifloxacin; COT: Cotrimoxazole.
ND: Not determined; NT: Non-typeable.
Spa types (bold) are new types; Isolates with spa type t064, t159, t311, t318, t934, 1510, t2216 and t2304 were assigned STs based on the Based Upon Repeat
Pattern (BURP) via the Ridom StaphType software. **: MLST on representative strains.
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2 Ogbomosho Wound Infection S. saprophyticus PEN, TET, COT, FUS - ND
4 Ogbomosho UTI S. saprophyticus PEN, TET, COT, FUS - ND
7 Ogbomosho Osteomyelitis S. saprophyticus PEN, TET, COT, FUS - ND
13B Ogbomosho UTI S. saprophyticus PEN, COT, FUS - ND
14ψ Ogbomosho Septicaemia S. sciuri PEN, OXA, GEN, CIP, FUS, MOX + NT/UNT
16 Ogbomosho SSI S. warneri PEN, TET, COT, FUS - ND
16B Ogbomosho Osteomyelitis S. warneri TET, COT, FUS - ND
18 Ogbomosho SSI S. saprophyticus PEN, TET, COT, FUS - ND
66 Lagos2 Wound Infection S. sciuri PEN, OXA, GEN, CIP, FUS + NT
L2ψ Lagos2 Septicaemia S. haemolyticus PEN, OXA, TET, COT + NT/V
L5 Lagos2 Eye swab S. haemolyticus PEN, OXA, CIP, MOX, TET, COT + NT
L6 Lagos2 Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, ERY, TET, RIF, COT + NT
L7 Lagos2 Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, MOX, ERY, TET, COT + NT
L8 Lagos2 Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, ERY, CLI*, TET, COT + NT
L9 Lagos2 Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, TET, COT + NT
L10 Lagos2 Eye swab S. haemolyticus PEN, OXA, GEN, CIP, MOX, ERY, TET, COT + NT
1103 Maiduguri Wound Infection S. warneri PEN, OXA, TET + NT
1268 Maiduguri Wound Infection S. haemolyticus PEN, OXA, GEN, CIP, MOX, TET, COT + NT
024ψ Maiduguri Wound Infection S. haemolyticus PEN, OXA, GEN, TET, COT + NT/V
2491 Maiduguri UTI S. haemolyticus PEN, OXA, GEN, CIP, ERY, TET, COT, TEICOi + NT
2412 Maiduguri Wound Infection S. haemolyticus PEN, OXA, GEN, CIP, MOX, TET, COT + NT
2362 ψ Maiduguri GTI S. haemolyticus PEN, OXA, GEN, CIP, ERY, CLI*, TET, COT + NT/UNT
825 Maiduguri GTI S. haemolyticus PEN, OXA, GEN, CIP, TET, COT + NT
2502 Maiduguri UTI S. haemolyticus PEN, OXA, GEN, COT ND ND
J2 Jos Septicaemia S. hominis PEN, OXA, TET ND ND
J5 Jos Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, ERY, CLI*, TET, RIF, COT ND ND
J6 Jos Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, ERY, CLI*, TET, RIF, COT ND ND
J10 Jos Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, ERY, CLI*, TET, RIF, COT ND ND
J14ψ Jos Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, ERY, TET, FUS, COT + NT/V
J15 Jos Prostatis S. haemolyticus PEN, OXA, TET, COT + NT
J16 Jos Otitis media S. haemolyticus PEN, OXA, GEN, CIP, COT + NT
J17B Jos Osteomyelitis S. epidermidis PEN, OXA, COT + NT
151 Ogbomosho Septicaemia S. haemolyticus PEN, OXA, GEN, CIP, MOX, TET, COT + NT
12 Ogbomosho Conjunctivitis S. sciuri PEN, OXA, GEN, CIP, FUS + NT
19B Ogbomosho SSI S. sciuri PEN, OXA, GEN, CIP, TET, FUS + NT
11 Ogbomosho Wound abscess S. sciuri PEN, OXA, GEN, CIP, FUS + NT
17 Ogbomosho Wound infection S. sciuri PEN, OXA, CIP, GEN, FUS + NT
11B Ogbomosho UTI S. sciuri PEN, OXA, GEN, CIP, MOX, FUS + NT
15 Ogbomosho UTI S. sciuri PEN, OXA, GEN, CIP, MOX, FUS + NT
6 Ogbomosho UTI S. sciuri PEN, OXA, GEN, CIP, FUS + NT
KEY:
ψ: Representative MRCNS for SCCmec typing determined by Kondo et al. (2007); UTI: Urinary Tract Infection; SSI: Skin and soft tissue infection; GTI: Genital Tract
Infection. Antibiotics - PEN: Penicillin; OXA: Oxacillin; GEN: Gentamicin; CIP: Ciprofloxacin; MOX: Moxifloxacin; ERY: Erythromycin; CLI: Clindamycin; TET: Tetracycline;
FUS: Fusidic acid; RIF: Rifampicin; COT: Cotrimoxazole; TEICO: Teicoplanin. *: Inducible resistance (clindamycin); ND: Not determined; NT: Non-typeable; UNT:
Untypeable SCCmec types.
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Table 4 Antibiotic resistance profile of staphylococci from
Nigeria
Number (%) of isolates resistant among
Antibiotics MSSA MRSA S. haemolyticus Others (CNS)
n=36 n=15 n=21 n=19
Penicillin 29 (80.6) 15 (100) 21 (100) 18 (94.7)
Oxacillin 0 (0) 15 (100) 21 (100) 12 (63.2)
Teicoplanin 0 (0) 0 (0) 1* (4.8) 0 (0)
Vancomycin 0 (0) 0 (00 0 (0) 0 (0)
Gentamicin 0 (0) 6 (40) 18 (85.7) 9 (47.4)
Tetracycline 21 (58.3) 13 (86.7) 19 (90.5) 9 (47.4)
Ciprofloxacin 2 (5.6) 7 (46.7) 17 (80.9) 9 (47.4)
Moxifloxacin 1 (2.8) 1 (6.7) 6 (28.6) 3 (15.8)
Erythromycin 0 (0) 5 (33.3) 10 (47.6) 0 (0)
Clindamycin 0 (0) 5 (33.3) 5 (23.8) 0 (0)
Fusidic acid 0 (0) 1 (6.7) 1 (4.8) 16 (84.2)
Tigecycline 0 (0) 0 (0) 0 (0) 0 (0)
Mupirocin 0 (0) 0 (0) 0 (0) 0 (0)
Linezolid 0 (0) 0 (0) 0 (0) 0 (0)
Rifampicin 0 (0) 2 (13.3) 4 (19) 0 (0)
Cotrimoxazole 29 (80.6) 13 (86.7) 21 (100) 8 (42.1)
*Intermediate resistance.
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molyticus possessed the SCCmec V element (ccrC/Class
C2 mec). However, untypeable SCCmec elements were
detected in two MRSA (ccrC/Class A mec and ccr-
negative/Class C2 mec) and one isolate each of S. sciuri
and S. haemolyticus (ccr-negative/Class A mec and ccr
type 4/Class C2 mec gene complex) (Tables 1 and 3).
Detection of PVL gene
One MRSA from Ile-Ife was PVL positive (Table 1). The
gene was also detected in 16 MSSA, of which 10 were
isolated from patients with SSI and septicaemia
(Table 2).
Molecular typing of MSSA and MRSA
A total of 21 spa types were identified and representative
S. aureus strains assigned as t037, t064, t084, t355,
t2331, t4690, and new types t8987 and t9008 were
selected for MLST (Tables 1 and 2). In MRSA, seven dif-
ferent spa types were identified and isolates with spa
types t037, t064, and t4690 were assigned ST241, ST8
and ST152, respectively. Overall, the clonal complexes
for MRSA were distributed across CC8, CC30, CC88
and ST152 (Table 2). In MSSA, fifteen different spa
types, including two new types (t8987 and t9008) were
identified of which only t064 was identified also in
MRSA (Tables 1 and 2). The predominant spa types
were t355 (8 isolates), t084 (7 isolates) and t318 (3 iso-
lates) and a diversity of spa types (t318, t1510, t2304,t2331, spa non-typeable) were identified among the
MSSA from nasal samples of health care workers
(HCWs) (Table 2). MSSA isolates with spa type t084
and t2331 were assigned ST15 and ST8 respectively,
while ST152 accounted for the new spa types (t8987,
t9008) and t355. Nine and 11 of the 36 MSSA clustered
with ST15 and ST152 respectively (Table 2).Discussion
The identification of bacterial isolates to species level is
of great importance in the clinical microbiology labora-
tory to obtain information on the diversity and signifi-
cance of each species in human infection. Moreover,
species identification is a prerequisite for epidemio-
logical studies. Many clinical microbiology laboratories
in Nigeria do not identify staphylococci (in particular
CNS) to species level, which is important in understand-
ing their variety and clinical relevance. Two species,
S. haemolyticus and S. sciuri, accounted for the majority
of the 40 CNS isolates investigated in this study (Table 3).
Most of the S. haemolyticus isolates were obtained from
blood culture samples in HCIs in Lagos2 and Jos, and
S. sciuri from samples in Ogbomosho (South-West
Nigeria). S. haemolyticus is regarded as the second most
frequently isolated staphylococci from blood cultures
[32] and one of the most clinically relevant CNS, par-
ticularly in immunocompromised patients [33]. S. sciuri,
principally found in animal species, and although not
considered important from the clinical standpoint, has
been associated with infections such as endocarditis
[34], urinary tract infection [35] and wound infections
[19,36]. Multiresistance to antibiotics was detected in
37 of the 40 CNS isolates, and all the S. haemolyticus
isolates were resistant to at least three classes of antibio-
tics. Apart from the possible clinical importance because
of its serious impact on the course of infection, multire-
sistant CNS are a potential source of genes encoding
resistance to antibiotics for other staphylococci patho-
genic for man. The isolation of multiresistant mecA posi-
tive S. haemolyticus from blood samples (septicaemia)
and S. sciuri from various clinical materials (Table 3) in
some HCIs clearly indicate that they could be of clinical
importance in Nigeria. A number of reports have indi-
cated an increase in the resistance of staphylococci
to cotrimoxazole in Nigeria [15,18,21,23,37]. In this
study, 72.5% of CNS and 82.3% of S. aureus isolates
were resistant to cotrimoxazole. The antibiotic has wide
clinical application, inexpensive, orally administered and
available over-the-counter where they are sold with
or without prescription in Nigeria. This could possibly
explain the high level of staphylococcal resistance
observed in this study. Most of the cotrimoxazole-
resistant S. aureus were dfrA-negative; hence more
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Methicillin resistance in staphylococci is due to the
expression of the mecA gene, which mediates penicillin
binding protein 2a (PBP2a), a transpeptidase with low
affinity for beta-lactams [7,38]. The mecA gene is carried
by a mobile genetic element (MGE) termed the staphylo-
coccal cassette chromosome (SCCmec), and though the
mec origin remains unknown, it has been suggested that
mecA CNS may act as potential SCCmec donor account-
ing for the rise of new MRSA clones [39]. Eleven
SCCmec elements have been described to date: SCCmec
I-IV [40-42], and V-XI [43-48], but few reports exist
on the detection of mecA gene and characterization of
SCCmec types in Nigeria [21-23]. There was excellent
correlation between results of antibiotic susceptibility
testing (VITEK) and detection of the mecA gene for the
confirmation of methicillin-resistant staphylococci.
However, the MRCNS were non-typeable using the
multiplex PCR protocol [26]. Based on the method of
Kondo et al. [27], the SCCmec V element (ccrC/Class
C2 mec) was identified in representative S. haemolyticus
isolates, as well as untypeable SCCmec elements (ccr-
negative/Class A mec and ccr type 4/Class C2 mec gene
complex) in one representative isolate each of S. sciuri
and S. haemolyticus (Table 3). Recent studies have indi-
cated that SCCmec V is the predominant element among
methicillin-resistant S. haemolyticus isolates [33,49]. To
the best of our knowledge, this is the first report on the
characterization of SCCmec elements in CNS in Nigeria.
It is likely that the mec gene complex and ccr genes
in CNS are diverse and distinct, and as indicated in pre-
vious reports [7,28], there is the need to develop new
classification schemes for non-typeable SCCmec types
in MRCNS.
Molecular typing of the MRSA isolates indicated that
two clones (CC8-SCCmecnon-typeable and CC88-
SCCmec IV) existed in Maiduguri, North-East Nigeria,
and four clones in South-West Nigeria (CC8-SCCmecIII/
IV/V; CC30-SCCmecII/III; CC88-SCCmecIV and ST152-
SCCmecnon-typeable) (Table 1). Previous studies on the
epidemiology of MRSA in Nigeria identified MRSA
clones t064-ST8-CC8 and t037-ST241-CC8 in South-
West and North-East Nigeria, respectively [22,23]. A
community-associated clone, CC88-MRSA-IV, previously
reported in Ibadan, Nigeria [21] was identified from
wound and blood samples in Maiduguri and Ile-Ife, how-
ever, we were unable to determine whether the isolates
were community-associated. Untypeable SCCmec types
(ccrC/Class A mec; ccr-negative/Class C2 mec) were
detected in two representative MRSA isolates, of which
one was a PVL-positive isolate (t4690-ST152) from a
patient with osteomyelitis in Ile-Ife (South-West Nigeria).The MSSA were assigned mainly to clonal complexes
CC5, CC8, CC15, CC30, CC45, CC80 and ST152
(Table 2). A high proportion of MSSA from Maiduguri
were grouped in ST15 or ST152 indicating that these
clones were successful in North East Nigeria. PVL-
encoding genes were detected in 16 MSSA (44.4%) iso-
lates belonging to almost all clonal complexes identified
in this study. Moreover, 56% of these strains were asso-
ciated with ST152 and 10 of 16 (62.5%) PVL positive
MSSA isolates were associated with SSI and septicaemia.
These observations confirm previous studies that PVL-
positive MSSA ST152 are widespread in African coun-
tries [50-52] including Nigeria [22,23]. Furthermore,
MSSA isolates (ST121) from nasal samples of HCWs
were PVL positive. Our data suggests that the sequence
types for pandemic PVL-positive MSSA identified in this
study did not function as a reservoir for PVL-positive
MRSA supporting the argument of Schaumburg et al.
[52] that the intimate inter-relation between PVL-positive
MSSA and MRSA, which could lead to the emergence
and spread of PVL-positive MRSA clones has not been
established. However, the detection of an ST152-PVL-
positive MRSA in this study suggests that surveillance for
this clone is strongly advocated in Nigeria.
Conclusions
This is the first multi-centre study on the characterization
of coagulase positive and negative staphylococci using
phenotypic and molecular methods in Nigeria. However,
there were a number of limitations in this study. The
number of isolates from the HCIs was low and variable
which did not allow for comparison of data among the
participating centres. Moreover, the diversity of the
staphylococci analysed in this study does not represent
their distribution patterns in health care institutions in
Nigeria. Lastly, we could not conduct full characterization
of the mecA-positive CNS isolates, and only representa-
tive isolates were selected for SCCmec typing and MLST.
However, this study has highlighted the importance of
species identification for CNS, their clinical relevance,
and the need for longitudinal multi-centre surveys to
provide data on antibiotic resistance and epidemiology of
the staphylococci in Nigeria. Characterization of multire-
sistant mecA positive S. haemolyticus and S. sciuri from
clinical samples is important in understanding their epi-
demiology within hospitals in Nigeria. The identification
of untypeable SCCmec types in the study will be further
evaluated and characterized; however, there is the need
to develop new SCCmec classification schemes for non-
typeable methicillin-resistant staphylococci. There is an
urgent need to curtail the spread and establishment
of PVL-positive MSSA, in particular, the MSSA ST152
clone, in Nigeria.
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